Spots Global Cancer Trial Database for leflunomide
Every month we try and update this database with for leflunomide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse | NCT00003775 | Brain and Centr... | leflunomide | 18 Years - | Pfizer | |
| Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations | NCT06229340 | RAS Mutation Ras (Kras or Nr... Colorectal Canc... Pancreas Cancer Lung Cancer Melanoma Refractory Canc... | Leflunomide The combination... | 18 Years - 85 Years | N.N. Petrov National Medical Research Center of Oncology | |
| Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma | NCT04508790 | Recurrent Plasm... Refractory Plas... | Dexamethasone Leflunomide Pomalidomide | 18 Years - | City of Hope Medical Center | |
| Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | NCT00004071 | Prostate Cancer | leflunomide mitoxantrone hy... prednisone | 18 Years - | Pfizer | |
| Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies | NCT05443425 | Acute Graft Ver... Hematopoietic a... | Cholestyramine Leflunomide Steroid Therapy | 18 Years - | City of Hope Medical Center | |
| Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients | NCT05014646 | Smoldering Plas... | Cholestyramine Leflunomide | 18 Years - | City of Hope Medical Center | |
| Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma | NCT02509052 | Recurrent Plasm... Refractory Plas... | Laboratory Biom... Leflunomide Pharmacological... | 18 Years - | City of Hope Medical Center | |
| Leflunomide in Patients With PTEN-null Advanced Solid Malignancies | NCT04997993 | PTEN-null Advan... | Leflunomide | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy | NCT01727193 | Myasthenia Grav... | Azathioprine Leflunomide | 12 Years - 65 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy | NCT04532372 | Hematopoietic a... Malignant Solid... Symptomatic COV... | Best Practice Leflunomide Placebo Adminis... | 18 Years - | City of Hope Medical Center | |
| Leflunomide in Previously Treated Metastatic Triple Negative Cancers | NCT03709446 | Breast Neoplasm... Breast Diseases Metastatic Trip... | Leflunomide | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations | NCT06229340 | RAS Mutation Ras (Kras or Nr... Colorectal Canc... Pancreas Cancer Lung Cancer Melanoma Refractory Canc... | Leflunomide The combination... | 18 Years - 85 Years | N.N. Petrov National Medical Research Center of Oncology | |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy | NCT04532372 | Hematopoietic a... Malignant Solid... Symptomatic COV... | Best Practice Leflunomide Placebo Adminis... | 18 Years - | City of Hope Medical Center | |
| Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma | NCT01611675 | Melanoma | Vemurafenib Leflunomide | 18 Years - | Massachusetts General Hospital | |
| Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse | NCT00003775 | Brain and Centr... | leflunomide | 18 Years - | Pfizer | |
| Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations | NCT06229340 | RAS Mutation Ras (Kras or Nr... Colorectal Canc... Pancreas Cancer Lung Cancer Melanoma Refractory Canc... | Leflunomide The combination... | 18 Years - 85 Years | N.N. Petrov National Medical Research Center of Oncology | |
| Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis | NCT03449758 | Rheumatoid Arth... | SARILUMAB Azathioprine Chloroquine Hydroxychloroqu... Leflunomide Methotrexate Sulfasalazine | 18 Years - | Sanofi | |
| Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma | NCT01611675 | Melanoma | Vemurafenib Leflunomide | 18 Years - | Massachusetts General Hospital | |
| Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma | NCT04370483 | Smoldering Plas... | Leflunomide Quality-of-Life... | 18 Years - | City of Hope Medical Center | |
| Leflunomide in Patients With PTEN-null Advanced Solid Malignancies | NCT04997993 | PTEN-null Advan... | Leflunomide | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Leflunomide in Previously Treated Metastatic Triple Negative Cancers | NCT03709446 | Breast Neoplasm... Breast Diseases Metastatic Trip... | Leflunomide | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme | NCT00003293 | Brain and Centr... | leflunomide procarbazine hy... | 18 Years - | Pfizer | |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy | NCT04532372 | Hematopoietic a... Malignant Solid... Symptomatic COV... | Best Practice Leflunomide Placebo Adminis... | 18 Years - | City of Hope Medical Center | |
| Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies | NCT05443425 | Acute Graft Ver... Hematopoietic a... | Cholestyramine Leflunomide Steroid Therapy | 18 Years - | City of Hope Medical Center | |
| Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | NCT00004071 | Prostate Cancer | leflunomide mitoxantrone hy... prednisone | 18 Years - | Pfizer | |
| Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma | NCT04508790 | Recurrent Plasm... Refractory Plas... | Dexamethasone Leflunomide Pomalidomide | 18 Years - | City of Hope Medical Center | |
| Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis | NCT03449758 | Rheumatoid Arth... | SARILUMAB Azathioprine Chloroquine Hydroxychloroqu... Leflunomide Methotrexate Sulfasalazine | 18 Years - | Sanofi | |
| The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy | NCT01727193 | Myasthenia Grav... | Azathioprine Leflunomide | 12 Years - 65 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy | NCT04532372 | Hematopoietic a... Malignant Solid... Symptomatic COV... | Best Practice Leflunomide Placebo Adminis... | 18 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
